These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22914202)

  • 21. Predictive and prognostic effect of CD133 and cancer-testis antigens in stage Ib-IIIA non-small cell lung cancer.
    Su C; Xu Y; Li X; Ren S; Zhao C; Hou L; Ye Z; Zhou C
    Int J Clin Exp Pathol; 2015; 8(5):5509-18. PubMed ID: 26191258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum MiRNA as Predictive and Prognosis Biomarker in Advanced Stage Non-small Cell Lung Cancer in Indonesia.
    Hanafi AR; Jayusman AM; Alfasunu S; Sadewa AH; Pramono D; Heriyanto DS; Haryana SM
    Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):321-332. PubMed ID: 32283582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Folate receptor α associated with triple-negative breast cancer and poor prognosis.
    Zhang Z; Wang J; Tacha DE; Li P; Bremer RE; Chen H; Wei B; Xiao X; Da J; Skinner K; Hicks DG; Bu H; Tang P
    Arch Pathol Lab Med; 2014 Jul; 138(7):890-5. PubMed ID: 24028341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined use of EpCAM and FRα enables the high-efficiency capture of circulating tumor cells in non-small cell lung cancer.
    Chen L; Peng M; Li N; Song Q; Yao Y; Xu B; Liu H; Ruan P
    Sci Rep; 2018 Jan; 8(1):1188. PubMed ID: 29352248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and significance of FRA-1 in non-small-cell lung cancer.
    Ma K; Chang D; Gong M; Ding F; Luo A; Tian F; Liu Z; Wang T
    Cancer Invest; 2009 Mar; 27(3):353-9. PubMed ID: 19160107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum folate receptor alpha as a biomarker for ovarian cancer: Implications for diagnosis, prognosis and predicting its local tumor expression.
    Kurosaki A; Hasegawa K; Kato T; Abe K; Hanaoka T; Miyara A; O'Shannessy DJ; Somers EB; Yasuda M; Sekino T; Fujiwara K
    Int J Cancer; 2016 Apr; 138(8):1994-2002. PubMed ID: 26595060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-Small-cell Lung Cancer Patients With Adenocarcinoma Morphology Have a Better Outcome Compared With Patients Diagnosed With Non-Small-cell Lung Cancer Favor Adenocarcinoma.
    Shiran I; Heller E; Jessel S; Kamer I; Daniel-Meshulam I; Navon R; Urban D; Onn A; Bar J
    Clin Lung Cancer; 2017 May; 18(3):316-323.e1. PubMed ID: 28237243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancer.
    Choi CM; Jang SJ; Park SY; Choi YB; Jeong JH; Kim DS; Kim HK; Park KS; Nam BH; Kim HR; ; Kim SY; Hong KM
    Mol Cancer; 2011 Sep; 10():119. PubMed ID: 21943122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of fluorodeoxyglucose uptake in non-small cell lung cancer. A blurry picture?
    Weber WA; Czernin J; Phelps ME
    Clin Cancer Res; 2007 Jun; 13(11):3105-6. PubMed ID: 17545510
    [No Abstract]   [Full Text] [Related]  

  • 30. Protein expression of close homologue of L1 (CHL1) is a marker for overall survival in non-small cell lung cancer (NSCLC).
    Hötzel J; Melling N; Müller J; Polonski A; Wolters-Eisfeld G; Izbicki JR; Karstens KF; Tachezy M
    J Cancer Res Clin Oncol; 2019 Sep; 145(9):2285-2292. PubMed ID: 31372722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Survival and prognostic factors of non small cell lung cancer: analytic review of 211 cases].
    Battikh MH; Ben Sayah MM; Joobeur S; Rouetbi N; Ben Salem K; Daami M; Maatallah A; Raham W; Farhat C; El Kamel A
    Tunis Med; 2004 Sep; 82(9):843-8. PubMed ID: 15693478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological markers in non-small cell lung cancer. Retrospective study of 10 year follow-up after surgery.
    Carbognani P; Tincani G; Crafa P; Sansebastiano G; Pazzini L; Zoni R; Bobbio A; Rusca M
    J Cardiovasc Surg (Torino); 2002 Aug; 43(4):545-8. PubMed ID: 12124571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic effect of matrix metalloproteinase-9 in patients with resected Non small cell lung cancer.
    Lee CY; Shim HS; Lee S; Lee JG; Kim DJ; Chung KY
    J Cardiothorac Surg; 2015 Mar; 10():44. PubMed ID: 25888323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tumor-associated prognostic parameters in non-small-cell bronchial carcinoma].
    Thomas M
    Pneumologie; 1997 Jul; 51(7):669-77. PubMed ID: 9333800
    [No Abstract]   [Full Text] [Related]  

  • 35. Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis.
    Pelletier MP; Edwardes MD; Michel RP; Halwani F; Morin JE
    Can J Surg; 2001 Jun; 44(3):180-8. PubMed ID: 11407827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aspects of diagnosis and staging of non-small-cell lung cancer.
    Larcos G
    Med J Aust; 1998 Mar; 168(5):256. PubMed ID: 9539911
    [No Abstract]   [Full Text] [Related]  

  • 37. Over-expression of EGFR is closely correlated to poor prognosis in Tunisian patients with non-small cell lung adenocarcinoma.
    Arfaoui A; Kriaa L; Znaidi N; Gritli S; Bouacha H; Zermani R; Rammeh S
    J Immunoassay Immunochem; 2014; 35(3):256-68. PubMed ID: 24654822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term survival and prognostic factors of five-year survivors with complete resection of non-small cell lung carcinoma.
    Okada M; Nishio W; Sakamoto T; Harada H; Uchino K; Tsubota N
    J Thorac Cardiovasc Surg; 2003 Aug; 126(2):558-62. PubMed ID: 12928658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic prediction of the immunohistochemical expression of p53 and p16 in resected non-small cell lung cancer.
    Cheng YL; Lee SC; Harn HJ; Chen CJ; Chang YC; Chen JC; Yu CP
    Eur J Cardiothorac Surg; 2003 Feb; 23(2):221-8. PubMed ID: 12559346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicenter trial of EC145 in advanced, folate-receptor positive adenocarcinoma of the lung.
    Edelman MJ; Harb WA; Pal SE; Boccia RV; Kraut MJ; Bonomi P; Conley BA; Rogers JS; Messmann RA; Garon EB
    J Thorac Oncol; 2012 Oct; 7(10):1618-21. PubMed ID: 22982661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.